Sign in

CIK 0001360214 · Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
450567010
Phone
615.733.4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. S-3/A Offering Registration Statement
  2. S-3 Offering Registration Statement
  3. 8-K Event Regulation FD disclosure
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 8-K Event Material agreement
  7. 4 Option exercise Director acquired 100,000 shares (option exercise)
  8. DEF 14A Proxy Proxy Statement
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 8-K Event Executive or director change
  13. 8-K Event Material agreement
  14. 8-K Event Material agreement
  15. SC 13G Stake Amended Statement of Ownership
  16. 424B5 Offering Prospectus
  17. 8-K Event Material agreement · Other events
  18. 8-K Event Results of operations
  19. 10-K Report Annual Report
  20. 4 Other disposition Director disposed of 20,000 shares (other)

Page 25 of 44 · 872 filings